2026 NPPES data Neuromuscular Medicine (Psychiatry & Neurology) Physician NPI 1346501350 D.O.
Verify on CMS →

SHAIDA KHAN, D.O.

Neuromuscular Medicine (Psychiatry & Neurology) Physician in DALLAS, Texas. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
976
Medicare Part D claims · 140 beneficiaries · Neuromuscular Medicine (Psychiatry & Neurology) Physician avg: 931
Generic prescribing
85%
generic claims · 15% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
74.5984/100
▼ 9 pts below national avg 83.1 · [object Object]
Industry payments
$9.1K
5 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: SHAIDA KHAN, D.O. is a Neuromuscular Medicine (Psychiatry & Neurology) Physician ([object Object]) practicing in DALLAS, Texas with a Medicare Part D prescribing footprint of 976 claims across 140 beneficiaries — 15% brand-name prescribing . Their CMS MIPS Final Score of 74.5984/100 (national average: 83.1) reflects performance across Quality, Cost, Interoperability, and Improvement Activities . Industry payments of $9.1K across 5 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: SHAIDA KHAN, D.O. reported a CMS MIPS final score of 74.5984 out of 100, below the 83.1 national average, and filed 976 Medicare Part D claims in 2023. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board certification likely (heuristic — not verified)

SHAIDA KHAN, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

SHAIDA KHAN, D.O. at a glance

Below national average

NPI registry status

Active

Issued 06/06/2012

NPI 1346501350

Primary specialty

Neuromuscular Medicine (Psychiatry & Neurology) Physician

Rare

336 US NPIs in this specialty

Medicare Part D claims

976 5% vs specialty avg

2023 prescription claims

Specialty avg: 931

MIPS final score

74.5984/100 8.501599999999996% pts

Mid-tier band

vs 83.1 national avg

Specialty distribution in Texas

How Neuromuscular Medicine (Psychiatry & Neurology) Physician compares to other specialties among Texas providers

Texas providers

Neuromuscular Medicine (Psychiatry & Neurology) Physician share within Texas

1. Neuromuscular Medicine (Psychiatry & Neurology) Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuromuscular Medicine (Psychiatry & Neurology) Physician share within Texas

Medicare quality performance — MIPS

SHAIDA KHAN, D.O.'s 2023 MIPS final score plotted against the Neuromuscular Medicine (Psychiatry & Neurology) Physician national average

Below national average
MIPS Final Score
74.5984/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) — 74.5984/100 vs national avg 83.1

0%100%National avg83%74.6%
MIPS final score (Neuromuscular Medicine (Psychiatry & Neurology) Physician) — 74.5984/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

SHAIDA KHAN, D.O. is a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider practicing in DALLAS, Texas, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: D.O.. NPI: 1346501350. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

SHAIDA KHAN, D.O. appears in the CMS NPPES registry as a Neuromuscular Medicine (Psychiatry & Neurology) Physician provider holding D.O. credentials at 5323 HARRY HINES BLVD, DALLAS, TX, 75390, with a listed phone of (214) 645-8800. NPI 1346501350 was issued on 06/06/2012. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what KHAN most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 976 prescription claims written by this provider, covering 140 Medicare beneficiaries and totaling roughly $3.0 million in drug spend, split 15% brand-name and 85% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 74.5984/100 for the 2023 performance year (Quality 56.1252, Cost 59.2027), compared with the national average of 83.1.

Neuromuscular Medicine (Psychiatry & Neurology) Physician is a narrow specialty nationwide, with 336 enrolled providers across 44 states and an average of 931 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

5323 HARRY HINES BLVD
DALLAS, TX 75390

Provider Details

NPI 1346501350
Specialty Neuromuscular Medicine (Psychiatry & Neurology) Physician
Credentials D.O.
Gender Female
NPI Issued 06/06/2012

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

74.5984
Final Score
Avg: 83.1
56.1252
Quality
59.2027
Cost
100
Promoting Interoperability

Reporting: Group practice

Hospital and facility affiliations

Facilities where SHAIDA KHAN, D.O. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER AT DALLAS
FORT WORTH, TX

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SHAIDA KHAN, D.O.. Source: openpaymentsdata.cms.gov.

Total received

$9.1K

Largest payer

UCB, Inc.

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Texas TMB 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~77K Texas medical licensees in 2023 — they are NOT specific to SHAIDA KHAN, D.O.. To verify SHAIDA KHAN, D.O.'s current license status, search the TMB public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

344
Total board actions, Texas 2023
Across 334 cases
4.47
Actions per 1,000 licensees
Texas statewide rate
probation
Most common action type
94 cases

TMB publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Texas disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

SHAIDA KHAN, D.O. — brand share 15.0%
Specialty average (est.)

15% brand-name claims vs 85% generic, on 976 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

976
Total Claims
$3.0M
Total Drug Cost
140
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
1,670
Total Day Supply
49,020
Brand vs Generic
15% brand / 85% generic
Brand Drug Cost
$2.9M
Generic Drug Cost
$74K

Patient Demographics

Average Patient Age
67.0 years
Avg HCC Risk Score
1.89
Gender Split
49% female / 51% male
Age Distribution
<65: 43, 65-74: 63, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Prednisone
157
Mycophenolate Mofetil
153
Pyridostigmine Bromide
139
Gabapentin
64
Azathioprine
50
Pantoprazole Sodium
32
Clonazepam
28
Gammagard Liquid
Immun Glob G(Igg)/Gly/Iga Ov50
28
Duloxetine Hcl
27
Famotidine
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuromuscular Medicine (Psychiatry & Neurology) Physician Overview

How SHAIDA KHAN, D.O. fits within the Neuromuscular Medicine (Psychiatry & Neurology) Physician landscape nationally.

336
Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in US
44
States with Neuromuscular Medicine (Psychiatry & Neurology) Physician
931
Avg Claims per Provider

SHAIDA KHAN, D.O.'s 976 claims are above the specialty average of 931.

Nearby Neuromuscular Medicine (Psychiatry & Neurology) Physician Providers in Texas

Other clinicians with the same primary specialty enrolled in Texas, drawn from the same CMS NPPES roster as KHAN.

Compare Neuromuscular Medicine (Psychiatry & Neurology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is SHAIDA KHAN, D.O.'s specialty?
SHAIDA KHAN, D.O. specializes in Neuromuscular Medicine (Psychiatry & Neurology) Physician and practices in DALLAS, Texas. Credentials: D.O..
How much does SHAIDA KHAN, D.O. prescribe under Medicare Part D?
In 2023, SHAIDA KHAN, D.O. wrote 976 Medicare Part D claims totaling $3.0M in drug costs for 140 beneficiaries.
What is SHAIDA KHAN, D.O.'s Medicare quality score?
SHAIDA KHAN, D.O. has a CMS MIPS Final Score of 74.5984/100 (Quality: 56.1252, Cost: 59.2027). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is SHAIDA KHAN, D.O. located?
SHAIDA KHAN, D.O. is located at 5323 HARRY HINES BLVD, DALLAS, TX, 75390. Phone: (214) 645-8800.
What is SHAIDA KHAN, D.O.'s NPI number?
SHAIDA KHAN, D.O.'s National Provider Identifier (NPI) is 1346501350, issued on 06/06/2012.
Does SHAIDA KHAN, D.O. prescribe more brand-name or generic drugs?
SHAIDA KHAN, D.O.'s prescribing is 15% brand-name and 85% generic drugs by claim count, with $2.9M in brand drug costs.
How many Neuromuscular Medicine (Psychiatry & Neurology) Physician providers are there in the US?
There are 336 Neuromuscular Medicine (Psychiatry & Neurology) Physician providers across 44 states in the US. The average Neuromuscular Medicine (Psychiatry & Neurology) Physician provider writes 931 Medicare Part D claims per year.
What drugs does SHAIDA KHAN, D.O. prescribe most often?
Based on 2023 Medicare Part D data, SHAIDA KHAN, D.O.'s most frequently prescribed drugs include Prednisone, Mycophenolate Mofetil, Pyridostigmine Bromide. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does SHAIDA KHAN, D.O. accept Medicare?
SHAIDA KHAN, D.O. appears in CMS Medicare data with 976 Part D claims and 140 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify SHAIDA KHAN, D.O.'s credentials?
SHAIDA KHAN, D.O.'s NPI is 1346501350 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology